Three Big Mistakes Drug Companies Make in Recruiting New Employees In the fast-paced world of biopharmaceuticals, recruiting top talent is […]
3 big mistakes drug companies make in recruiting new employees Read Post »
The biopharmaceutical industry stands at a crossroads. The era of blockbuster drugs, once the lifeblood of big pharma, is waning.
As blockbuster drugs fizzle, biotech looks warily to the next big thing Read Post »
File this under ‘unintended consequences.’ A number of health care organizations are complaining that a final guideline the US Food
By Dylan Scott, Posted with permission from STAT Mark Cuban has something to say about prescription drug prices. The billionaire
Some Biosimilars Are Just as Good as Some Pricey Biologics: A Game-Changer in Healthcare In the world of medicine, we’re
Some biosimilars are just as good as some pricey biologics Read Post »
Hermann A. M. Mucke*, H. M. Pharma Consultancy, Wien, Austria A Multimodal Approach to the Re-development of Drugs Drug repositioning—the
Drug Repositioning in the Mirror of Patenting: Surveying and Mining Uncharted Territory Read Post »
Share your expertise with our expansive network > Go to submission form < Do you want to reach a large
Get fresh news and insights, drug patent expirations & more…
